Treatment Association Directory
Opioid Treatment Programs
Search 1,590 programs offering medication-assisted treatment for opioid use disorder.
Treatment Association Directory
Search 1,590 programs offering medication-assisted treatment for opioid use disorder.
The opioid crisis has claimed over 500,000 American lives since 1999, with fentanyl now driving the majority of overdose deaths. Medication-assisted treatment (MAT) is the gold standard for opioid use disorder — reducing overdose deaths by approximately 50% and significantly improving recovery outcomes compared to abstinence-only approaches.
Our directory includes 1,590 opioid treatment programs offering MAT with buprenorphine (Suboxone), methadone, naltrexone (Vivitrol), and comprehensive behavioral therapy.
Three FDA-approved medications treat opioid use disorder. Buprenorphine (Suboxone, Sublocade) is a partial opioid agonist that reduces cravings and withdrawal without producing the full opioid high. It can be prescribed by certified physicians in office settings, making it the most accessible MAT option. Methadone is a full opioid agonist administered daily at licensed clinics. It is highly effective for severe opioid dependence and has the longest track record. Naltrexone (Vivitrol) is an opioid antagonist that blocks opioid effects entirely. Administered as a monthly injection, it is an option for patients who have completed detox and prefer a non-opioid approach. All three medications are most effective when combined with behavioral therapy — counseling, CBT, contingency management, and peer support.
MAT is recommended for anyone with opioid use disorder, including prescription opioid dependence, heroin addiction, fentanyl addiction, and people who have relapsed after previous treatment attempts. Research consistently shows that MAT is superior to abstinence-only treatment for opioid use disorder. It is not "replacing one drug with another" — it is evidence-based medical treatment that stabilizes brain chemistry, reduces overdose risk, and creates the stability needed for long-term recovery.
When evaluating opioid treatment programs, ask which MAT medications they offer (programs that offer all three provide the most flexibility), whether they provide integrated behavioral therapy alongside medication, how they handle dose adjustments and ongoing monitoring, what their approach is to treatment duration (longer MAT is associated with better outcomes), and whether they provide or coordinate with detox services for initial stabilization. Programs that pressure patients to taper off MAT quickly may not be following current clinical guidelines.
Browse by state
Search our verified directory or call for free guidance.